Clinical trial
Retrospective Study of Implants With Peri-implantitis Surgically Treated Using Enamel Matrix Derivative (EMD)
NCT05419102 is registered in ClinicalTrials.gov with North Dallas Dental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study of Implants With Peri-implantitis Surgically Treated Using Enamel Matrix Derivative (EMD)
- Lead sponsor
- North Dallas Dental Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- June 6, 2022
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
determination of beneficial effect of using enamel matrix derivative during implant treatment